Britta Höchsmann

3.0k total citations · 1 hit paper
65 papers, 1.6k citations indexed

About

Britta Höchsmann is a scholar working on Immunology, Hematology and Nephrology. According to data from OpenAlex, Britta Höchsmann has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 40 papers in Hematology and 20 papers in Nephrology. Recurrent topics in Britta Höchsmann's work include Complement system in diseases (43 papers), Renal Diseases and Glomerulopathies (20 papers) and Blood groups and transfusion (19 papers). Britta Höchsmann is often cited by papers focused on Complement system in diseases (43 papers), Renal Diseases and Glomerulopathies (20 papers) and Blood groups and transfusion (19 papers). Britta Höchsmann collaborates with scholars based in Germany, United States and United Kingdom. Britta Höchsmann's co-authors include Hubert Schrezenmeier, Antonio M. Risitano, Alexander Röth, Ilene C. Weitz, Christoph Q. Schmidt, Jeff Szer, Jens Panse, Markus Anliker, Thomas Simmet and Andrea Bacigalupo and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Blood.

In The Last Decade

Britta Höchsmann

60 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

2021 249 citations Peter Hillmen, Jeff Szer et al. profile →

Peers

Britta Höchsmann

IMMUN

HEMAT

NEPHR

GENET

PHYSI

Hirohito Yamazaki Japan

Sara Gastoldi Italy

Ann‐Charlotte Kristoffersson Sweden

Kenji Soejima Japan

Jean‐Claude Davin Netherlands

Wendell Rosse United States

Jessica Caprioli Italy

Rasha Aguzzi United States

CE van der Schoot Netherlands

Hilde De Winter United States

Hirohito Yamazaki Japan

Britta Höchsmann

692 ×0.7

IMMUN

1.0k ×1.2

HEMAT

163 ×0.3

NEPHR

240 ×0.6

GENET

32 ×0.2

PHYSI

Citations per year, relative to Britta Höchsmann Britta Höchsmann (= 1×) peers Hirohito Yamazaki

Countries citing papers authored by Britta Höchsmann

Since Specialization

Citations

This map shows the geographic impact of Britta Höchsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Höchsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Höchsmann more than expected).

Fields of papers citing papers by Britta Höchsmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Höchsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Höchsmann. The network helps show where Britta Höchsmann may publish in the future.

Co-authorship network of co-authors of Britta Höchsmann

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Höchsmann. A scholar is included among the top collaborators of Britta Höchsmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Höchsmann. Britta Höchsmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Höchsmann, Britta, et al.. (2026). Ravulizumab for Treatment of Paroxysmal Nocturnal Hemoglobinuria During Pregnancy. Blood Advances.

Höchsmann, Britta, et al.. (2025). Senescent erythrocytes as a trigger of complement activation and implications for breakthrough haemolysis in paroxysmal nocturnal haemoglobinuria patients. Immunobiology. 230(4). 153046–153046.

Schmidt, Christoph Q., Britta Höchsmann, & Hubert Schrezenmeier. (2024). The complement model disease paroxysmal nocturnal hemoglobinuria. European Journal of Immunology. 54(11). e2350817–e2350817. 4 indexed citations

Panse, Jens, Britta Höchsmann, & Jörg Schubert. (2024). Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment. Transfusion Medicine and Hemotherapy. 51(5). 310–320. 1 indexed citations

Höchsmann, Britta, Régis Peffault de Latour, A. Bradford Hill, et al.. (2023). Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry. Annals of Hematology. 102(11). 2979–2988. 9 indexed citations

Anliker, Markus, Lorin Loacker, Susanne Häfner, et al.. (2022). Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation. The Journal of Immunology. 208(5). 1248–1258. 3 indexed citations

Latour, Régis Peffault de, Jeff Szer, Ilene C. Weitz, et al.. (2022). Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial. The Lancet Haematology. 9(9). e648–e659. 43 indexed citations

Aljurf, Mahmoud, Mansour Alfayez, Andrea Bacigalupo, et al.. (2021). Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Transplantation and Cellular Therapy. 28(2). 105.e1–105.e7. 12 indexed citations

Hevey, Rachel, Mara Guariento, Britta Höchsmann, et al.. (2021). Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces. Frontiers in Immunology. 12. 615748–615748. 13 indexed citations

10.

Zolk, Oliver, Rebecca Halbgebauer, Britta Höchsmann, et al.. (2020). Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity. Blood. 137(4). 443–455. 65 indexed citations

11.

Elgohary, Ghada, Riad El Fakih, Antonio M. Risitano, et al.. (2020). Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT). Bone Marrow Transplantation. 55(10). 1906–1917. 40 indexed citations

12.

Weitz, Howard H., Peter Hillmen, Jeff Szer, et al.. (2020). RESULTS OF THE PEGASUS PHASE 3 RANDOMIZED TRIAL DEMONSTRATING SUPERIORITY OF THE C3 INHIBITOR PEGCETACOPLAN COMPARED TO ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. Hematology Transfusion and Cell Therapy. 42. 12–13. 2 indexed citations

13.

Bacigalupo, Andrea, Rosi Oneto, Hubert Schrezenmeier, et al.. (2018). First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001‐2012. American Journal of Hematology. 93(5). 643–648. 34 indexed citations

14.

Singer, Susanne, Alexander Röth, Hubert Schrezenmeier, et al.. (2016). Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)—report on phases I and II. Annals of Hematology. 96(2). 171–181. 27 indexed citations

15.

Höchsmann, Britta, et al.. (2013). Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in Germany. Annals of Hematology. 92(6). 825–830. 3 indexed citations

16.

Schrezenmeier, Hubert, Peter Bettelheim, Jens Panse, et al.. (2012). Recommendations for the diagnosis of paroxysmal nocturnal hemoglobinuria: a German-Austrian Consensus1). LaboratoriumsMedizin. 35(6). 2 indexed citations

17.

Höchsmann, Britta, et al.. (2012). Supportive care in severe and very severe aplastic anemia. Bone Marrow Transplantation. 48(2). 168–173. 42 indexed citations

18.

Nolte, Florian, Britta Höchsmann, Aristoteles Giagounidis, et al.. (2012). Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload. Annals of Hematology. 92(2). 191–198. 64 indexed citations

19.

Höchsmann, Britta, Markus Rojewski, & Hubert Schrezenmeier. (2011). Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes. Annals of Hematology. 90(8). 887–899. 31 indexed citations

20.

Schrezenmeier, Hubert & Britta Höchsmann. (2009). The Management of Paroxysmal Nocturnal Hemoglobinuria—Recent Advances in Diagnosis and Treatment, and New Hope for Patients. 2. 74–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact